Pear therapeutics to participate in evercore isi 5th annual healthconx conference

Boston--( business wire )--pear therapeutics, inc. (nasdaq: pear), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (pdts), today announced the company will participate in the evercore isi 5th annual healthconx conference on wednesday, november 30, 2022. corey mccann, m.d., ph.d., president and ceo, will participate in a virtual fireside chat at 12:10 p.m. et.
PEAR Ratings Summary
PEAR Quant Ranking